Shares of ANI Pharmaceuticals Inc. have been upgraded from a sell rating to a hold rating in a research report published by Zack Investment Research. ANI Pharmaceuticals is a specialty pharmaceutical company active in development, manufacturing, and marketing of generic prescription pharmaceuticals. The Company specializes in sectors, including anti-cancer (oncolytics), controlled substances, hormones & steroids, and complex formulations.
Other analysts have also issued reports about stocks of ANI. A buy rating has been restated by Guggenheim and a target price of $80.00 has been issued on shares. According to a research note by TheStreet, the shares of the company have been downgraded from b-rating to c-rating. As per the research note published on 4th March, 2017 by Roth Capital, ANI Pharmaceuticals got a hold rating and target price was set at $56.00. As per the research notes published by various investment analysts, three analysts have given a hold rating, three have given a buy rating, while one has given a strong buy rating. The stock of company has a consensus rating as Buy with an average price target of $67.83.
Request sample report @ http://bit.ly/2ppEGp6
ANI Pharmaceuticals has issued earning results of last quarter on 4th March, 2017. As per the report, %0.74 EPS was noted for the quarter. The company missed the consensus estimate of Zack Investment Research of $0.77 by $0.03. It earned $36.60 million in the last quarter, while consensus estimate was $39.63 million. The return on equity achieved by the company was 21.84%, while a net margin achieved was 7.28%. The revenue was raised to 77.7% based on year-over-year. In the same quarter past year, the company’s earnings per share was $0.76. As per the forecasts of analysts, the company would reach $3.87 earnings per share in the current year.
Various manufacturers are operating in the industry and investment firms looking for gaining maximum returns on their investments. In its recent report on the global specialty pharmaceuticals market, Big Market Research outlines competitive landscape and market estimations by 2022. Insights on various parameters in this report would help investors, market players, and new entrants to determine investment pockets and devise strategies for growth in the industry. The report also offers insights on sales, revenue, market share, and growth rate of key manufacturers operating in the industry. Detailed segmentation and changing market dynamics are offered to help market players and investors gain thorough understanding of the market.
Ask for discount @ http://bit.ly/2pREOjL